TARPON SPRINGS, Fla., May 7 /PRNewswire/ -- Methadone medication frequently depresses estradiol, progesterone and testosterone hormone levels to menopausal levels, even in women less than thirty years old. Hormonal suppression, caused by methadone, can cause depression, anxiety, fatigue, weight gain, bone loss, bladder pain, decreased pain tolerance, hot flashes, and increased risk for heart attack and stroke.
Dr. Rick Sponaugle, Medical Director of Florida Detox, observed, "Thirty of the last thirty female methadone patients, between 20 and 30 years old, who we detoxed from methadone arrived with estradiol, progesterone or testosterone hormone levels, in the post menopausal range."
A 1975 University of Pennsylvania study revealed severe hormonal suppression caused by narcotic pain medications. Despite this study, most methadone patients report physicians prescribing methadone failed to inform them of hormonal suppression risks caused by methadone. Physicians prescribing methadone, Vicodin, Oxycontin, Percocet, morphine and other opiate pain medications, seldom test or treat patients for hormonal deficiencies caused by these medications.
Although studies reveal methadone and other opiate pain medications do not benefit fibromyalgia patients, physicians frequently prescribe opiate pain medications to fibromyalgia patients. Fibromyalgia patients frequently become addicted to ineffective opiate pain medications, including methadone.
Many methadone patients are unable to persevere through painful methadone withdrawal symptoms, when methadone ceases providing pain relief. Methadone withdrawal symptoms frequently include anxiety, depression, insomnia, chills and sweats, diarrhea, nausea, muscle cramps and tremors and can include potentially deadly, heart rate and blood pressure increases. Depression and fatigue from methadone withdrawal frequently lasts a year, without effective ad
Page: 1 2 Related medicine technology :1
|SOURCE Florida Detox and Wellness Institute|
Copyright©2009 PR Newswire.
All rights reserved
. New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer2
. St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse3
. Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented4
. PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients5
. Gene That Causes Childhood Cancer Neuroblastoma Is Found6
. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community7
. SuperGens PIM Kinase Inhibitor, SGI-1776, Causes Tumor Regression in AML Xenograft Models8
. SuperGen Identifies Lead PIM Kinase Inhibitor, SGI-1776, That Causes Tumor Regression in AML Xenograft Models9
. Mayo Clinic Study Identifies Potential Causes of Young-Onset Dementia10
. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer11
. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature